|

Effects of Cold Atmospheric Plasma (CAP) on Peritoneal Tumor Tissue

RECRUITINGN/ASponsored by University Hospital, Ghent
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital, Ghent
Started2024-08-21
Est. completion2025-04-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06796634

Summary

There are to date no studies available that have examined the effects of CAP on tumor tissue in patients. The aim of this study is to investigate these effects in patients undergoing surgery for peritoneal metastases. Tumor nodules will be treated with different durations and intensities of CAP before being surgically removed. The resected nodules will be analyzed for tumor vitality.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion criteria:

* Patients with peritoneal metastases undergoing surgery (CRS, debulking), irrespective of the origin. Potential cancer types include ovarian cancer, colorectal cancer, and malignant peritoneal mesothelioma
* Written informed consent
* Age ≥ 18 years.

Conditions4

CancerCold Atmospheric Plasma (CAP)J-PlasmaPeritoneal Tumor

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.